vs
ExlService Holdings, Inc.(EXLS)とSelectQuote, Inc.(SLQT)の財務データ比較。上の社名をクリックして会社を切り替えられます
ExlService Holdings, Inc.の直近四半期売上が大きい($542.6M vs $537.1M、SelectQuote, Inc.の約1.0倍)。SelectQuote, Inc.の純利益率が高く(12.9% vs 11.1%、差は1.8%)。ExlService Holdings, Inc.の前年同期比売上増加率が高い(12.7% vs 11.6%)。ExlService Holdings, Inc.の直近四半期フリーキャッシュフローが多い($106.5M vs $-1.0M)。過去8四半期でSelectQuote, Inc.の売上複合成長率が高い(19.5% vs 11.5%)
ExlService Holdings Inc.は保険、ヘルスケア、銀行・金融サービス、メディア、小売などの業界を対象に分析・デジタルソリューションを提供するグローバル企業で、本社はニューヨークに所在し、米国、欧州、アジア、中南米、オーストラリア、南アフリカなど世界各地に5万4000人以上の専門スタッフを擁しています。
SelectQuoteは消費者向け直接販売プラットフォームで、保険契約と医療サービスを提供しています。消費者と保険会社を結びつけることで手数料を得て、シニア健康保険、生命保険、自動車保険、住宅保険を扱っています。医療サービスは認定薬局SelectRxを中心とし、2020年5月に上場しました。
EXLS vs SLQT — 直接比較
損益計算書 — Q4 FY2025 vs Q2 FY2026
| 指標 | ||
|---|---|---|
| 売上 | $542.6M | $537.1M |
| 純利益 | $60.2M | $69.3M |
| 粗利率 | 38.6% | 61.8% |
| 営業利益率 | 14.4% | 14.0% |
| 純利益率 | 11.1% | 12.9% |
| 売上前年比 | 12.7% | 11.6% |
| 純利益前年比 | 18.9% | 30.2% |
| EPS(希薄化後) | $0.38 | $0.26 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $542.6M | $537.1M | ||
| Q3 25 | $529.6M | $328.8M | ||
| Q2 25 | $514.5M | $345.1M | ||
| Q1 25 | $501.0M | $408.2M | ||
| Q4 24 | $481.4M | $481.1M | ||
| Q3 24 | $472.1M | $292.3M | ||
| Q2 24 | $448.4M | $307.2M | ||
| Q1 24 | $436.5M | $376.4M |
| Q4 25 | $60.2M | $69.3M | ||
| Q3 25 | $58.2M | $-30.5M | ||
| Q2 25 | $66.1M | $12.9M | ||
| Q1 25 | $66.6M | $26.0M | ||
| Q4 24 | $50.7M | $53.2M | ||
| Q3 24 | $53.0M | $-44.5M | ||
| Q2 24 | $45.8M | $-31.0M | ||
| Q1 24 | $48.8M | $8.6M |
| Q4 25 | 38.6% | 61.8% | ||
| Q3 25 | 38.5% | 41.4% | ||
| Q2 25 | 37.7% | 47.2% | ||
| Q1 25 | 38.6% | 60.2% | ||
| Q4 24 | 38.1% | 67.5% | ||
| Q3 24 | 37.8% | 55.7% | ||
| Q2 24 | 37.1% | 60.7% | ||
| Q1 24 | 37.4% | 71.8% |
| Q4 25 | 14.4% | 14.0% | ||
| Q3 25 | 14.4% | -12.4% | ||
| Q2 25 | 15.8% | -3.6% | ||
| Q1 25 | 15.7% | 5.4% | ||
| Q4 24 | 14.8% | 14.7% | ||
| Q3 24 | 14.7% | -4.1% | ||
| Q2 24 | 13.7% | -0.5% | ||
| Q1 24 | 14.1% | 8.8% |
| Q4 25 | 11.1% | 12.9% | ||
| Q3 25 | 11.0% | -9.3% | ||
| Q2 25 | 12.8% | 3.7% | ||
| Q1 25 | 13.3% | 6.4% | ||
| Q4 24 | 10.5% | 11.1% | ||
| Q3 24 | 11.2% | -15.2% | ||
| Q2 24 | 10.2% | -10.1% | ||
| Q1 24 | 11.2% | 2.3% |
| Q4 25 | $0.38 | $0.26 | ||
| Q3 25 | $0.36 | $-0.26 | ||
| Q2 25 | $0.40 | $-0.06 | ||
| Q1 25 | $0.40 | $0.03 | ||
| Q4 24 | $0.31 | $0.30 | ||
| Q3 24 | $0.33 | $-0.26 | ||
| Q2 24 | $0.28 | $-0.17 | ||
| Q1 24 | $0.29 | $0.05 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | ||
|---|---|---|
| 現金・短期投資手元流動性 | $328.4M | $18.3M |
| 総負債低いほど良い | $298.6M | $405.8M |
| 株主資本純資産 | $912.7M | $359.7M |
| 総資産 | $1.7B | $1.4B |
| 負債/資本比率低いほどレバレッジが低い | 0.33× | 1.13× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $328.4M | $18.3M | ||
| Q3 25 | $390.1M | $10.7M | ||
| Q2 25 | $353.3M | $32.4M | ||
| Q1 25 | $331.4M | $80.1M | ||
| Q4 24 | $340.6M | $7.3M | ||
| Q3 24 | $325.8M | $10.4M | ||
| Q2 24 | $276.1M | $42.7M | ||
| Q1 24 | $246.2M | $37.8M |
| Q4 25 | $298.6M | $405.8M | ||
| Q3 25 | $354.8M | $393.1M | ||
| Q2 25 | $260.0M | $385.1M | ||
| Q1 25 | $307.3M | $391.5M | ||
| Q4 24 | $288.5M | $711.9M | ||
| Q3 24 | $344.7M | $680.4M | ||
| Q2 24 | — | $683.3M | ||
| Q1 24 | — | $686.0M |
| Q4 25 | $912.7M | $359.7M | ||
| Q3 25 | $952.4M | $305.1M | ||
| Q2 25 | $1.1B | $351.1M | ||
| Q1 25 | $1.0B | $350.2M | ||
| Q4 24 | $929.9M | $326.0M | ||
| Q3 24 | $907.6M | $269.4M | ||
| Q2 24 | $852.6M | $316.8M | ||
| Q1 24 | $803.3M | $346.8M |
| Q4 25 | $1.7B | $1.4B | ||
| Q3 25 | $1.7B | $1.2B | ||
| Q2 25 | $1.7B | $1.2B | ||
| Q1 25 | $1.7B | $1.3B | ||
| Q4 24 | $1.6B | $1.3B | ||
| Q3 24 | $1.6B | $1.1B | ||
| Q2 24 | $1.5B | $1.2B | ||
| Q1 24 | $1.4B | $1.2B |
| Q4 25 | 0.33× | 1.13× | ||
| Q3 25 | 0.37× | 1.29× | ||
| Q2 25 | 0.25× | 1.10× | ||
| Q1 25 | 0.30× | 1.12× | ||
| Q4 24 | 0.31× | 2.18× | ||
| Q3 24 | 0.38× | 2.53× | ||
| Q2 24 | — | 2.16× | ||
| Q1 24 | — | 1.98× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | ||
|---|---|---|
| 営業キャッシュフロー直近四半期 | $117.4M | $52.0K |
| フリーキャッシュフロー営業CF - 設備投資 | $106.5M | $-1.0M |
| FCFマージンFCF / 売上 | 19.6% | -0.2% |
| 設備投資強度設備投資 / 売上 | 2.0% | 0.2% |
| キャッシュ転換率営業CF / 純利益 | 1.95× | 0.00× |
| 直近12ヶ月FCF直近4四半期 | $298.1M | $8.5M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $117.4M | $52.0K | ||
| Q3 25 | $120.7M | $-21.6M | ||
| Q2 25 | $109.4M | $-37.5M | ||
| Q1 25 | $3.2M | $71.1M | ||
| Q4 24 | $105.3M | $-28.7M | ||
| Q3 24 | $110.1M | $-16.6M | ||
| Q2 24 | $74.9M | $20.0M | ||
| Q1 24 | $-21.9M | $44.5M |
| Q4 25 | $106.5M | $-1.0M | ||
| Q3 25 | $106.4M | $-22.7M | ||
| Q2 25 | $95.0M | $-38.0M | ||
| Q1 25 | $-9.7M | $70.2M | ||
| Q4 24 | $95.3M | $-29.0M | ||
| Q3 24 | $97.3M | $-17.1M | ||
| Q2 24 | $62.8M | $19.7M | ||
| Q1 24 | $-33.1M | $43.4M |
| Q4 25 | 19.6% | -0.2% | ||
| Q3 25 | 20.1% | -6.9% | ||
| Q2 25 | 18.5% | -11.0% | ||
| Q1 25 | -1.9% | 17.2% | ||
| Q4 24 | 19.8% | -6.0% | ||
| Q3 24 | 20.6% | -5.8% | ||
| Q2 24 | 14.0% | 6.4% | ||
| Q1 24 | -7.6% | 11.5% |
| Q4 25 | 2.0% | 0.2% | ||
| Q3 25 | 2.7% | 0.3% | ||
| Q2 25 | 2.8% | 0.1% | ||
| Q1 25 | 2.6% | 0.2% | ||
| Q4 24 | 2.1% | 0.1% | ||
| Q3 24 | 2.7% | 0.2% | ||
| Q2 24 | 2.7% | 0.1% | ||
| Q1 24 | 2.6% | 0.3% |
| Q4 25 | 1.95× | 0.00× | ||
| Q3 25 | 2.08× | — | ||
| Q2 25 | 1.66× | -2.91× | ||
| Q1 25 | 0.05× | 2.73× | ||
| Q4 24 | 2.08× | -0.54× | ||
| Q3 24 | 2.08× | — | ||
| Q2 24 | 1.63× | — | ||
| Q1 24 | -0.45× | 5.20× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
EXLS
| Insurance | $185.8M | 34% |
| Healthcare And Life Sciences | $142.2M | 26% |
| Banking Capital Markets And Diversified Industries | $122.6M | 23% |
| International Growth Markets | $92.0M | 17% |
SLQT
| Healthcare Services Segment | $230.7M | 43% |
| Pharmacy | $227.2M | 42% |
| Other | $30.4M | 6% |
| Final Expense | $20.4M | 4% |
| Term | $18.5M | 3% |
| Other Senior | $6.3M | 1% |
| All Other Revenue | $3.9M | 1% |